Cullinan Therapeutics has announced a licensing agreement with Genrix Bio for global rights to velinotamig, a clinical-stage ...

T cells are the immune system’s frontline fighters. When they detect danger, they rapidly multiply and transform into ...

A Melbourne hospital has successfully treated an incurable auto-immune condition with a “game-changing” cancer therapy for ...

The HHS secretary said people should have access to experimental therapies including unregulated uses of stem cells. But some ...

Autoimmune disease symptoms vary greatly depending on which part of the body is affected, but some common symptoms include ...

In return for the ex-China rights to its new addition, called velinotamig, Cullinan has agreed to pay Genrix Bio the upfront ...

SHREVEPORT, La. - May is National Lupus Month and there's an event in Shreveport to spread awareness through North Louisiana.

New study finds that elevated S100A8/A9 levels in blood may be associated with cognitive impairment in adults with #lupus.

Monash Health, in collaboration with Monash University, has reached a ground-breaking milestone in the treatment of autoimmune diseases, successfully treating the first lupus patient in Australia with ...

Researchers found cannabinoids can inhibit the production of inflammatory cytokines and promote regulatory T cells, which are crucial for maintaining immune balance. This immunosuppressive potential ...

Genrix’s velinotamig complements Cullinan’s own pipeline, according to William Blair, which added that the deal will put ...